Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Monday Apr 24, 2023
Monday Apr 24, 2023
touchCONGRESS for touchONCOLOGY
Listen to renowned renal cell carcinoma (RCC) expert Prof. Brian Rini review key data presented at the ASCO GU 2023 congress on advances in immune checkpoint inhibitor (ICI)-based regimens for RCC. He also discusses with two additional leading RCC experts, Prof. Elizabeth Plimack and Prof. Thomas Powles, how these data may apply in clinical practice.
Overview:
- Data reviews with Prof. Brian Rini
- Expert panel discussions with Prof. Brian Rini, Prof. Elizabeth Plimack and Prof. Thomas Powles on the themes below
Clinical themes:
- ICI-based combinations in the treatment of advanced/metastatic RCC: What do the latest efficacy and safety data show?
- What is the potential role of biomarkers in predicting response to ICI-based combinations in patients with advanced/metastatic RCC?
- How might the latest data for ICI-based combinations for advanced/metastatic RCC be implemented in clinical practice?
The internationally renowned RCC expert faculty:
- Prof. Brian Rini, Vanderbilt University Medical Center, Nashville, TN, USA
- Prof. Elizabeth Plimack, Fox Chase Cancer Center, Philadelphia, PA, USA
- Prof. Thomas Powles, Barts Cancer Centre, St Bartholomew’s Hospital, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co. Inc. and Exelixis Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.